Nausea (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nausea" in Italian language version.

refsWebsite

Global rank Italian rank

18nih.gov

4^th place

9^th place

10doi.org

2^nd place

7^th place

1treccani.it

182^nd place

6^th place

1springer.com

274^th place

393^rd place

doi.org

dx.doi.org

(EN) U. Schutter, S. Grunert e C. Meyer, Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice, in Current Medical Research and Opinion, vol. 26, n. 6, 2010-06, pp. 1377–1387, DOI:10.1185/03007991003787318, PMID 20380506. URL consultato il 23 dicembre 2022.
(EN) C. Lindley, J. S. McCune e T. E. Thomason, Perception of chemotherapy side effects cancer versus noncancer patients, in Cancer Practice, vol. 7, n. 2, 1999, pp. 59–65, DOI:10.1046/j.1523-5394.1999.07205.x, PMID 10352062. URL consultato il 23 dicembre 2022.
(EN) Camilo Rojas e Barbara S. Slusher, Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting, in European Journal of Pharmacology, vol. 684, n. 1-3, 5 giugno 2012, pp. 1–7, DOI:10.1016/j.ejphar.2012.01.046, PMID 22425650. URL consultato il 23 dicembre 2022.
(EN) Matti Aapro, 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment, in Oncology, vol. 69, n. 2, 2005, pp. 97–109, DOI:10.1159/000087979, PMID 16131816. URL consultato il 23 dicembre 2022.
(EN) M. Marty, P. Pouillart e S. Scholl, Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis, in The New England Journal of Medicine, vol. 322, n. 12, 22 marzo 1990, pp. 816–821, DOI:10.1056/NEJM199003223221205, PMID 2137902. URL consultato il 23 dicembre 2022.
(EN) David G. Warr, Paul J. Hesketh e Richard J. Gralla, Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy, in Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 23, n. 12, 20 aprile 2005, pp. 2822–2830, DOI:10.1200/JCO.2005.09.050, PMID 15837996. URL consultato il 23 dicembre 2022.
(EN) Fausto Roila, David Warr e Rebecca A. Clark-Snow, Delayed emesis: moderately emetogenic chemotherapy, in Supportive Care in Cancer, vol. 13, n. 2, 2005-02, pp. 104–108, DOI:10.1007/s00520-004-0700-8. URL consultato il 23 dicembre 2022.
(EN) Julie L. Ryan, Charles E. Heckler e Joseph A. Roscoe, Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients, in Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 20, n. 7, 2012-07, pp. 1479–1489, DOI:10.1007/s00520-011-1236-3, PMID 21818642. URL consultato il 23 dicembre 2022.
(EN) Franjo Grotenhermen e Kirsten Müller-Vahl, The therapeutic potential of cannabis and cannabinoids, in Deutsches Arzteblatt International, vol. 109, n. 29-30, 2012-07, pp. 495–501, DOI:10.3238/arztebl.2012.0495, PMID 23008748. URL consultato il 23 dicembre 2022.
(EN) Lynn A. Anderson e Jeffrey B. Gross, Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea, in Journal of Perianesthesia Nursing: Official Journal of the American Society of PeriAnesthesia Nurses, vol. 19, n. 1, 2004-02, pp. 29–35, DOI:10.1016/j.jopan.2003.11.001, PMID 14770380. URL consultato il 23 dicembre 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

(EN) U. Schutter, S. Grunert e C. Meyer, Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice, in Current Medical Research and Opinion, vol. 26, n. 6, 2010-06, pp. 1377–1387, DOI:10.1185/03007991003787318, PMID 20380506. URL consultato il 23 dicembre 2022.
(EN) C. Lindley, J. S. McCune e T. E. Thomason, Perception of chemotherapy side effects cancer versus noncancer patients, in Cancer Practice, vol. 7, n. 2, 1999, pp. 59–65, DOI:10.1046/j.1523-5394.1999.07205.x, PMID 10352062. URL consultato il 23 dicembre 2022.
(EN) Camilo Rojas e Barbara S. Slusher, Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting, in European Journal of Pharmacology, vol. 684, n. 1-3, 5 giugno 2012, pp. 1–7, DOI:10.1016/j.ejphar.2012.01.046, PMID 22425650. URL consultato il 23 dicembre 2022.
(EN) Matti Aapro, 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment, in Oncology, vol. 69, n. 2, 2005, pp. 97–109, DOI:10.1159/000087979, PMID 16131816. URL consultato il 23 dicembre 2022.
(EN) M. Marty, P. Pouillart e S. Scholl, Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis, in The New England Journal of Medicine, vol. 322, n. 12, 22 marzo 1990, pp. 816–821, DOI:10.1056/NEJM199003223221205, PMID 2137902. URL consultato il 23 dicembre 2022.
(EN) David G. Warr, Paul J. Hesketh e Richard J. Gralla, Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy, in Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 23, n. 12, 20 aprile 2005, pp. 2822–2830, DOI:10.1200/JCO.2005.09.050, PMID 15837996. URL consultato il 23 dicembre 2022.
(EN) Julie L. Ryan, Charles E. Heckler e Joseph A. Roscoe, Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients, in Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 20, n. 7, 2012-07, pp. 1479–1489, DOI:10.1007/s00520-011-1236-3, PMID 21818642. URL consultato il 23 dicembre 2022.
(EN) Franjo Grotenhermen e Kirsten Müller-Vahl, The therapeutic potential of cannabis and cannabinoids, in Deutsches Arzteblatt International, vol. 109, n. 29-30, 2012-07, pp. 495–501, DOI:10.3238/arztebl.2012.0495, PMID 23008748. URL consultato il 23 dicembre 2022.
(EN) Lynn A. Anderson e Jeffrey B. Gross, Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea, in Journal of Perianesthesia Nursing: Official Journal of the American Society of PeriAnesthesia Nurses, vol. 19, n. 1, 2004-02, pp. 29–35, DOI:10.1016/j.jopan.2003.11.001, PMID 14770380. URL consultato il 23 dicembre 2022.

ncbi.nlm.nih.gov

(EN) U. Schutter, S. Grunert e C. Meyer, Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice, in Current Medical Research and Opinion, vol. 26, n. 6, 2010-06, pp. 1377–1387, DOI:10.1185/03007991003787318, PMID 20380506. URL consultato il 23 dicembre 2022.
(EN) C. Lindley, J. S. McCune e T. E. Thomason, Perception of chemotherapy side effects cancer versus noncancer patients, in Cancer Practice, vol. 7, n. 2, 1999, pp. 59–65, DOI:10.1046/j.1523-5394.1999.07205.x, PMID 10352062. URL consultato il 23 dicembre 2022.
(EN) Camilo Rojas e Barbara S. Slusher, Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting, in European Journal of Pharmacology, vol. 684, n. 1-3, 5 giugno 2012, pp. 1–7, DOI:10.1016/j.ejphar.2012.01.046, PMID 22425650. URL consultato il 23 dicembre 2022.
(EN) Matti Aapro, 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment, in Oncology, vol. 69, n. 2, 2005, pp. 97–109, DOI:10.1159/000087979, PMID 16131816. URL consultato il 23 dicembre 2022.
(EN) M. Marty, P. Pouillart e S. Scholl, Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis, in The New England Journal of Medicine, vol. 322, n. 12, 22 marzo 1990, pp. 816–821, DOI:10.1056/NEJM199003223221205, PMID 2137902. URL consultato il 23 dicembre 2022.
(EN) David G. Warr, Paul J. Hesketh e Richard J. Gralla, Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy, in Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol. 23, n. 12, 20 aprile 2005, pp. 2822–2830, DOI:10.1200/JCO.2005.09.050, PMID 15837996. URL consultato il 23 dicembre 2022.
(EN) Julie L. Ryan, Charles E. Heckler e Joseph A. Roscoe, Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients, in Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 20, n. 7, 2012-07, pp. 1479–1489, DOI:10.1007/s00520-011-1236-3, PMID 21818642. URL consultato il 23 dicembre 2022.
(EN) Franjo Grotenhermen e Kirsten Müller-Vahl, The therapeutic potential of cannabis and cannabinoids, in Deutsches Arzteblatt International, vol. 109, n. 29-30, 2012-07, pp. 495–501, DOI:10.3238/arztebl.2012.0495, PMID 23008748. URL consultato il 23 dicembre 2022.
(EN) Lynn A. Anderson e Jeffrey B. Gross, Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea, in Journal of Perianesthesia Nursing: Official Journal of the American Society of PeriAnesthesia Nurses, vol. 19, n. 1, 2004-02, pp. 29–35, DOI:10.1016/j.jopan.2003.11.001, PMID 14770380. URL consultato il 23 dicembre 2022.

springer.com

link.springer.com

(EN) Fausto Roila, David Warr e Rebecca A. Clark-Snow, Delayed emesis: moderately emetogenic chemotherapy, in Supportive Care in Cancer, vol. 13, n. 2, 2005-02, pp. 104–108, DOI:10.1007/s00520-004-0700-8. URL consultato il 23 dicembre 2022.

treccani.it

Nausea, in Treccani.it – Vocabolario Treccani on line, Roma, Istituto dell'Enciclopedia Italiana. URL consultato il 23 dicembre 2022.